Legal Representation
Attorney
Ann Lamport Hammitte
USPTO Deadlines
Application History
16 eventsDate | Code | Type | Description |
---|---|---|---|
Dec 10, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Dec 10, 2018 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
May 8, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 13, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 13, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Feb 21, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jan 31, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 31, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 30, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jan 30, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Aug 3, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN |
Aug 3, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED |
Aug 3, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jul 31, 2017 | DOCK | D | ASSIGNED TO EXAMINER |
May 9, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
May 6, 2017 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Scientific research, scientific research for others in the treatment of hemophilia; consulting services in the field of researching and development of pharmaceutical preparations for the treatment of hemophilia
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042